Colonoscopy demand is surging as colorectal cancer rates rise and screening guidelines expand eligibility, creating what some are calling a “gold rush” for GI and ambulatory surgery centers (ASCs).
While procedure volumes continue to climb and more colonoscopies shift into outpatient settings, the economics are becoming increasingly complex. GI procedures now represent a major share of ASC activity, and specialized GI centers are rapidly expanding. However, declining reimbursements are putting pressure on margins, forcing GI groups to rethink operational models, site-of-care strategy, and long-term growth plans.
The article also highlights a growing disconnect in GI economics: demand for endoscopy has likely never been higher, yet reimbursement pressure continues to intensify.